Media Releases and Task Force Announcements

Media Releases and Task Force Announcements2021-02-26T17:28:04-05:00

Latest findings reveal few Canadian adults have antibodies to SARS-Cov-2

Canadian Blood Services and the CITF’s collaborative nine-province SARS-CoV-2 seroprevalence study for October thru November suggests that 1.5 per cent of healthy Canadians had been exposed to SARS-CoV-2. The highest levels were recorded in Western Canada but mass national vaccination remains only route to achieving herd immunity.

January 25, 2021|Media Releases, Seroprevalence studies|

Will one dose of the COVID-19 vaccine be enough?

OP-ED, CHARU KAUSHIC AND CATHERINE HANKINS, CONTRIBUTED TO THE GLOBE AND MAIL, JANUARY 7, 2021 Charu Kaushic is a professor of pathology and molecular medicine at McMaster University. Catherine Hankins is a professor of public and population Health at McGill University. Both are members of the COVID-19 Immunity Task Force. This year is starting on an [...]

January 8, 2021|Media Releases|

Study finds few youths on the West Island and in the Plateau have had diagnosed cases of COVID-19, but mental health is an issue

Preliminary results from a study underway in Montreal suggest 41% of 1,000 children surveyed so far, largely based on participants from the West Island and the Plateau, have gone to get tested to see if they were infected at the time with SARS-CoV-2, the virus that causes COVID-19. Of those, 99% tested negative. In this surveyed group, children from 10 households also had family members test positive for SARS-CoV-2, yet only one child from these households tested positive.

December 14, 2020|Media Releases, Pediatric studies|

The COVENANT Study: COVID-19 Cohort Study of People Experiencing Homelessness in Toronto

COVID-19 poses a serious health threat to people experiencing homelessness. Homelessness puts people at high risk during the COVID-19 pandemic, as shelters are an ideal environment for the transmission of SARS-CoV-2, the virus that causes COVID-19. More than 235,000 Canadians experience homelessness every year. Recruitment starts soon for the COVENANT study, which will provide critical [...]

December 10, 2020|Media Releases|

Two studies will help determine whether health care workers in Canada are at higher risk of contracting SARS-CoV-2

Preliminary, non-peer reviewed results suggest that in phase 1 of a study on healthcare workers led by Dr. Nicola Cherry at the University of Alberta, rates of infection were higher in physicians than in other HCWs and higher in Quebec physicians than among physicians in Alberta.

November 26, 2020|Healthcare workers studies, Media Releases|

New study to determine how many Canadians have been infected with SARS-CoV-2

Canada’s COVID-19 Immunity Task Force (CITF) is supporting a new study to identify how many Canadians have been previously infected with SARS-CoV-2, the virus that causes COVID-19. The project, conducted by Statistics Canada, will be the first to use a nationally representative sample to reflect COVID-19 seroprevalence right across Canada at national, provincial, and territorial [...]

November 9, 2020|Media Releases|

Canada’s COVID-19 Immunity Task Force funds national study looking at seroprevalence of COVID-19 antibodies among high-risk populations

The Government of Canada is investing $1.9 million through Canada’s COVID-19 Immunity Task Force (CITF) to fund a Canadian Partnership for Tomorrow’s Health (CanPath) study looking at COVID-19 seroprevalence across Canada, with a particular focus on certain populations that are at higher risk of infection.  CanPath is a national population health research platform that follows the health of 330,000 Canadians (or 1% [...]

October 28, 2020|Media Releases|

Study underway in Montreal to estimate how many children and teens have been infected with SARS-CoV-2

Today, Canada’s COVID-19 Immunity Task Force (CITF) announces its support for a research project that will estimate how many children and teens in Montreal have been infected with SARS-CoV-2, the virus that causes COVID-19. This $720,000 investment will allow us to better understand how much virus transmission has occurred to children and teens, and will [...]

October 20, 2020|Media Releases|

Investing in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians

Canada's COVID-19 Immunity Task Force (CITF) announces its support for a new SARS-CoV-2 seroprevalence study focused on aging Canadians, a population that has been shown to be at greatest risk for severe outcomes from COVID-19 disease.  This $4 million investment will be carried out by the Canadian Longitudinal Study on Aging (CLSA), a national platform for research on [...]

October 1, 2020|Media Releases|
Go to Top